Privia Health Income Statement (2020-2026) | PRVA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
225.76M251.52M275.33M313.80M335.54M342.90M364.42M386.28M413.35M417.28M440.83M415.24M422.33M437.92M460.90M480.10M521.15M580.42M541.17M603.85M
Operating items
Research & Development (Quarter)
11.18M4.59M3.80M4.66M4.82M5.09M5.17M5.29M5.96M7.24M6.25M6.08M6.85M7.05M6.46M6.92M6.80M6.96M6.45M8.13M
Selling, General & Administrative (Quarter)
168.66M33.91M39.32M36.11M33.11M32.22M28.16M25.95M26.81M27.23M29.60M32.12M28.92M30.70M34.42M31.72M37.52M39.64M29.27M41.47M
Other Operating Expenses (Quarter)
239.11M225.84M251.56M284.58M302.86M310.17M328.85M348.32M373.61M377.28M403.56M376.21M381.46M394.37M414.76M436.24M473.49M519.41M494.18M546.82M
Operating Expenses (Quarter)
418.94M264.33M294.68M325.35M340.79M347.47M362.18M379.56M406.37M411.75M439.41M414.42M417.23M432.11M455.65M474.88M517.82M566.02M529.89M596.42M
Operating Income (Quarter)
-193.19M-12.81M-19.35M-11.55M-5.25M-4.57M2.25M6.71M6.98M5.54M1.42M0.82M5.10M5.81M5.25M5.22M3.34M14.40M11.28M7.42M
EBIT (Quarter)
-193.19M-12.81M-19.35M-11.55M-5.25M-4.57M2.25M6.71M6.98M5.54M1.42M0.82M5.10M5.81M5.25M5.22M3.34M14.40M11.28M7.42M
Non-operating items
Non Operating Income (Quarter)
0.82M2.89M2.85M2.98M2.97M2.16M2.77M2.93M2.41M2.27M2.09M1.89M
Net income details
EBT (Quarter)
-193.49M-13.10M-19.53M-11.78M-5.91M-4.29M3.40M8.53M7.80M8.43M4.27M3.81M8.06M7.98M8.02M8.15M5.74M16.67M13.37M9.31M
Tax Provisions (Quarter)
-20.00M-2.21M-7.66M6.31M5.47M-4.80M-13.42M2.10M1.40M2.49M1.99M0.80M3.40M4.00M2.63M2.10M2.50M6.87M2.79M5.60M
Profit After Tax (Quarter)
-173.49M-9.12M-14.40M-18.09M-11.38M0.56M16.85M6.40M6.36M5.64M2.32M3.06M4.64M3.98M4.40M6.05M3.29M9.81M3.78M3.06M
Income from Non-Controlling Interests (Quarter)
-0.95M-1.78M0.09M-0.58M-0.91M-1.07M-0.93M-0.92M-0.91M0.30M-0.51M0.07M1.18M0.44M0.97M1.83M0.60M2.95M1.43M0.65M
Income from Continuing Operations (Quarter)
-173.49M-10.89M-11.88M-18.09M-11.38M0.51M16.82M6.43M6.40M5.94M2.27M3.01M4.66M3.98M5.40M6.05M3.24M9.81M10.59M3.71M
Consolidated Net Income (Quarter)
-173.49M-10.89M-11.88M-18.09M-11.38M0.51M16.82M6.43M6.40M5.94M2.27M3.01M4.66M3.98M5.40M6.05M3.24M9.81M10.59M3.71M
Income towards Parent Company (Quarter)
-173.49M-10.89M-11.88M-18.09M-11.38M0.51M16.82M6.43M6.40M5.94M2.27M3.01M4.66M3.98M5.40M6.05M3.24M9.81M10.59M3.71M
Net Income towards Common Stockholders (Quarter)
-173.49M-10.89M-11.88M-18.09M-11.38M0.51M16.82M6.43M6.40M5.94M2.27M3.01M4.66M3.98M5.40M6.05M3.24M9.81M10.59M3.71M
Additional items
EPS (Basic) (Quarter)
-1.69-0.10-0.12-0.17-0.100.000.150.060.060.050.020.030.040.030.050.050.030.080.090.03
EPS (Diluted) (Quarter)
-1.69-0.10-0.12-0.17-0.100.000.150.050.050.050.020.020.040.030.040.050.030.080.080.03
Shares Outstanding (Quarter)
102.74M105.90M102.95M108.06M108.69M111.59M110.70M115.01M116.16M117.60M116.73M118.51M119.30M119.66M119.40M120.62M122.13M122.77M122.18M124.15M
Shares Outstanding (Diluted) (Quarter)
102.74M105.90M102.95M108.06M108.69M124.85M110.70M124.33M124.57M124.92M124.69M125.05M125.32M125.75M125.61M127.75M128.45M128.78M128.89M130.88M
EBITDA (Quarter)
-193.19M-12.81M-19.35M-11.55M-5.25M-4.57M2.25M6.71M6.98M5.54M1.42M0.82M5.10M5.81M5.25M5.22M3.34M14.40M11.28M7.42M
Interest Expenses (Quarter)
0.39M0.39M-0.74M404.13M417.25M371.85M3.42M243.65M194.32M143.24M107.32M92.20M90.39M0.06M103.87M102.95M113.72M0.06M83.30M
Tax Rate (Quarter)
10.34%16.87%39.20%-53.55%-92.47%111.91%-394.47%24.63%17.96%29.51%46.70%21.01%42.16%50.13%32.73%25.77%43.52%41.18%20.84%60.15%